ATE245035T1 - Diagnostische zusammensetzungen und deren anwendung in der diagnose von zentralnervösen anomalien - Google Patents

Diagnostische zusammensetzungen und deren anwendung in der diagnose von zentralnervösen anomalien

Info

Publication number
ATE245035T1
ATE245035T1 AT96926003T AT96926003T ATE245035T1 AT E245035 T1 ATE245035 T1 AT E245035T1 AT 96926003 T AT96926003 T AT 96926003T AT 96926003 T AT96926003 T AT 96926003T AT E245035 T1 ATE245035 T1 AT E245035T1
Authority
AT
Austria
Prior art keywords
anomalies
diagnosis
application
central nervous
diagnostic compositions
Prior art date
Application number
AT96926003T
Other languages
English (en)
Inventor
Masahiro Kajiwara
Tsuyoshi Hirose
Nobuhiro Ikei
Original Assignee
Otsuka Pharma Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Otsuka Pharma Co Ltd filed Critical Otsuka Pharma Co Ltd
Application granted granted Critical
Publication of ATE245035T1 publication Critical patent/ATE245035T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/12—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by a special physical form, e.g. emulsion, microcapsules, liposomes, characterized by a special physical form, e.g. emulsions, dispersions, microcapsules
    • A61K51/1206—Administration of radioactive gases, aerosols or breath tests
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2123/00—Preparations for testing in vivo

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Dispersion Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Optics & Photonics (AREA)
  • Atmospheric Sciences (AREA)
  • Epidemiology (AREA)
  • Physics & Mathematics (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Other Investigation Or Analysis Of Materials By Electrical Means (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Medicines Containing Plant Substances (AREA)
AT96926003T 1995-08-08 1996-08-06 Diagnostische zusammensetzungen und deren anwendung in der diagnose von zentralnervösen anomalien ATE245035T1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP20258095 1995-08-08
JP704396 1996-01-19
PCT/JP1996/002206 WO1997005906A2 (en) 1995-08-08 1996-08-06 Diagnostic and diagnosis method for central nervous abnormality and phenylketonuria

Publications (1)

Publication Number Publication Date
ATE245035T1 true ATE245035T1 (de) 2003-08-15

Family

ID=26341285

Family Applications (1)

Application Number Title Priority Date Filing Date
AT96926003T ATE245035T1 (de) 1995-08-08 1996-08-06 Diagnostische zusammensetzungen und deren anwendung in der diagnose von zentralnervösen anomalien

Country Status (13)

Country Link
US (1) US5916537A (de)
EP (1) EP0781145B1 (de)
JP (1) JP3635346B2 (de)
AR (1) AR003975A1 (de)
AT (1) ATE245035T1 (de)
AU (1) AU6631296A (de)
CA (1) CA2201620C (de)
DE (1) DE69629097T2 (de)
DK (1) DK0781145T3 (de)
ES (1) ES2201190T3 (de)
MX (1) MX9702602A (de)
PT (1) PT781145E (de)
WO (1) WO1997005906A2 (de)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6764817B1 (en) * 1999-04-20 2004-07-20 Target Discovery, Inc. Methods for conducting metabolic analyses
IL161498A0 (en) * 2001-10-24 2004-09-27 Univ California Measurement of protein synthesis rates in humans and experimental system by use of isotopically labeled water
WO2003068919A2 (en) 2002-02-12 2003-08-21 The Regents Of The University Of California Non-invasive method for measuring rates of biosynthesis of biological molecules by label incorporation
WO2004011426A2 (en) 2002-07-30 2004-02-05 The Regents Of The University Of California Method for automated, large-scale measurement of the molecular flux rates of the proteome or the organeome using mass spectrometry
AU2003268416A1 (en) * 2002-09-04 2004-03-29 The Regents Of The University Of California Methods for measuring rates of replication and death of nfectious microbial agents in an infected host organism
ATE415486T1 (de) * 2002-09-13 2008-12-15 Univ California Verfahren zur messung der geschwindigkeiten des cholesterinrückwärtstransports in vivo als index für anti-artherogenese
US20070248540A1 (en) * 2002-09-16 2007-10-25 The Regents Of The University Of California Biochemical methods for measuring metabolic fitness of tissues or whole organisms
AU2003291731B2 (en) 2002-11-04 2009-09-10 The Regents Of The University Of California Deuterated glucose or fat tolerance tests for high-throughput measurement of the metabolism of sugars or fatty acids in the body
US7262020B2 (en) * 2003-07-03 2007-08-28 The Regents Of The University Of California Methods for comparing relative flux rates of two or more biological molecules in vivo through a single protocol
US20050202406A1 (en) 2003-11-25 2005-09-15 The Regents Of The University Of California Method for high-throughput screening of compounds and combinations of compounds for discovery and quantification of actions, particularly unanticipated therapeutic or toxic actions, in biological systems
CA2553223A1 (en) * 2004-01-15 2005-08-04 Cedars-Sinai Medical Center System and method for expression proteomics based on isotope ratio modification
TW200538738A (en) 2004-02-20 2005-12-01 Univ California Molecular flux rates through critical pathways measured by stable isotope labeling in vivo, as biomarkers of drug action and disease activity
WO2005087943A1 (en) * 2004-03-11 2005-09-22 The Regents Of The University Of California Temporal or spatial characterization of biosynthetic events in living organisms by isotopic fingerprinting under conditions of imposed isotopic gradients
US20050238577A1 (en) * 2004-03-29 2005-10-27 The Regents Of The University Of California Isolation of epithelial cells or their biochemical contents from excreta after in vivo isotopic labeling
US20060183238A1 (en) * 2005-02-09 2006-08-17 Applera Corporation Amine-containing compound analysis methods
JP4118918B2 (ja) * 2005-02-28 2008-07-16 シャープ株式会社 信号品質評価装置、情報記録再生装置、信号品質評価方法、記録条件決定方法、信号品質評価プログラム、信号品質評価プログラムを記録したコンピュータ読み取り可能な記録媒体
TW200711660A (en) * 2005-06-10 2007-04-01 Univ California Monitoring two dimensions of diabetes pathogenesis separately or concurrently (insulin sensitivity and beta-cell sufficiency): uses in diagnosis, prognosis, assessment of disease risk, and drug development
SI1898961T1 (sl) * 2005-06-30 2014-08-29 Otsuka America Pharmaceutical, Inc. Postopek za individualiziranje levodopa/karbidopa terapije ob uporabi dihalnega testa
US20110319699A1 (en) * 2009-03-11 2011-12-29 Electricite De France Carbonaceous radioactive waste treatment
US9061006B2 (en) 2011-03-08 2015-06-23 Ramot At Tel-Aviv University Ltd. Compositions and methods for diagnosing and treating phenylketonuria (PKU)
JP2014526685A (ja) 2011-09-08 2014-10-06 ザ・リージェンツ・オブ・ザ・ユニバーシティ・オブ・カリフォルニア 代謝流量測定、画像化、および顕微鏡法
JP6294233B2 (ja) 2011-12-07 2018-03-14 グラクソスミスクライン エルエルシー 全身骨格筋量の定量方法
US9134319B2 (en) 2013-03-15 2015-09-15 The Regents Of The University Of California Method for replacing biomarkers of protein kinetics from tissue samples by biomarkers of protein kinetics from body fluids after isotopic labeling in vivo
CN109796329A (zh) * 2019-03-26 2019-05-24 上海化工研究院有限公司 一种13C标记α-氨基丁酸的合成方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0828934B2 (ja) * 1984-07-31 1996-03-21 株式会社東芝 保護制御装置
US5320825A (en) * 1991-05-01 1994-06-14 Trustees Of The University Of Pennsylvania Serotonin reuptake inhibitors for S.P.E.C.T. imaging
JP2844503B2 (ja) * 1991-11-20 1999-01-06 東京瓦斯株式会社 ガス測定装置
US5386832A (en) * 1993-06-11 1995-02-07 New England Deaconess Hospital Liver function breath test using aromatic amino acids
US5707602A (en) * 1996-03-25 1998-01-13 Meretek Diagnostics Measurement of gastric emptying

Also Published As

Publication number Publication date
ES2201190T3 (es) 2004-03-16
DK0781145T3 (da) 2003-10-13
CA2201620A1 (en) 1997-02-20
JPH09257791A (ja) 1997-10-03
JP3635346B2 (ja) 2005-04-06
WO1997005906A2 (en) 1997-02-20
AU6631296A (en) 1997-03-05
EP0781145A1 (de) 1997-07-02
PT781145E (pt) 2003-11-28
EP0781145B1 (de) 2003-07-16
US5916537A (en) 1999-06-29
CA2201620C (en) 2007-01-09
AR003975A1 (es) 1998-09-30
DE69629097T2 (de) 2004-03-18
WO1997005906A3 (en) 1997-05-29
DE69629097D1 (de) 2003-08-21
MX9702602A (es) 1997-07-31

Similar Documents

Publication Publication Date Title
ATE245035T1 (de) Diagnostische zusammensetzungen und deren anwendung in der diagnose von zentralnervösen anomalien
DE3887830D1 (de) Viskoelastische Reinigungsmittel und deren Anwendung.
DE69520194D1 (de) Zusammensetzungen zum Herstellen von Kapselhüllen und deren Anwendung
DE69429768D1 (de) Diagnose und behandlung von erektilen funktionsstörungen
DE69533336D1 (de) Testkarte und ihre anwendung
EP0677556A3 (de) Beschichtetes Pigment und Farbstoffzusammensetzung.
DE69101922D1 (de) Verwendung von pyrimidin-3-oxydderivaten zur verhütung von haarausfall und deren anwendung in topischen zusammensetzungen.
ATE179325T1 (de) Oxidationsfärbemittel für keratinische fasern und färbeverfahren mit diesem mittel
DE3776827D1 (de) Niedrigtoxische oelzusammensetzung und anwendung in bohrfluessigkeiten.
ATE273301T1 (de) Substituierte aza- und diazacycloheptan- und - cyclooctanverbindungen und deren verwendung
ATE156348T1 (de) Oxydationsfärbemittel für keratinische fasern und färbeverfahren mit demselben mittel
DE69514526D1 (de) Träger und dessen Anwendung bei der Aufbereitung von spektroskopischen Proben
DE60223547D1 (de) Gangliosid-assoziierte rekombinante antikörper und deren verwendung bei der diagnose und behandlung von tumoren
DE69131765D1 (de) Polyviologenmodifizierte Elektrode und deren Anwendung
DE69228492D1 (de) 3,4,N-Trisubstituierte-4,5-dihydro-1H-Pyrazol-1-carboxamide und deren Anwendung als Insektizide
ATE282400T1 (de) Oxidationszusammensetzung und verwendungen derselben für die behandlung von keratinischen fasern
DE69800737D1 (de) Verfahren zur Herstellung von kationischen Zellulosemicrofasern oder deren löslichen Derivaten und Zellulose hergestellt durch dieses Verfahren
DE69831334T2 (de) Oxydierungszusammensetzung zur anwendung in der behandlung von keratinischen fasern
DE68917352D1 (de) Trimethylolheptane und ihre Anwendung.
DE69024779D1 (de) Kern-Schale-Polymer und dessen Anwendung
DE69517345D1 (de) Abziehbarer Verbundstoff und seiner Verwendung bei der Herstellung von Ausgleichsscheiben
ATE183774T1 (de) Löslicher interferon-rezeptor, seine herstellung und anwendung
DE69028579D1 (de) Glas-Metalldichtungen und ihre Anwendung
DE69010743D1 (de) Silikometallatmolekularsiebe und deren Anwendung als Katalysatoren bei der Oxydierung von Alkanen.
DE69222158D1 (de) Zinkphosphatmolekularsiebe und deren Anwendung für Adsorption und Katalyse

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 0781145

Country of ref document: EP

REN Ceased due to non-payment of the annual fee